sinapinic acid has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avcı, E; Eroğlu, C; Kurar, E; Vural, H | 1 |
| Akl, MR; Cardelli, JA; Dragoi, AM; Dykes, S; Ebrahim, HY; El Sayed, KA; Mohyeldin, MM | 1 |
2 other study(ies) available for sinapinic acid and Cancer of Prostate
| Article | Year |
|---|---|
Anticancer mechanism of Sinapic acid in PC-3 and LNCaP human prostate cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Coumaric Acids; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Male; Prostatic Neoplasms | 2018 |
The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor.
Topics: Animals; Antineoplastic Agents; Binding Sites; Breast Neoplasms; Catalysis; Cell Movement; Cell Proliferation; Coumaric Acids; Dose-Response Relationship, Drug; Female; Humans; Male; MCF-7 Cells; Mice, Nude; Molecular Docking Simulation; Molecular Structure; Neoplasm Invasiveness; Phosphorylation; Point Mutation; Prostatic Neoplasms; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Signal Transduction; Spheroids, Cellular; Structure-Activity Relationship; Time Factors; Xenograft Model Antitumor Assays | 2016 |